Search term:

Directory A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z KuDOS Pharmaceuticals Kodak European Research Keronite Kherion Technology KPMG Kerio Technologies

Top 20 Companies Abcam Amino Technologies ANT plc ARM Holdings Autonomy AVEVA Bango Brady CSR Cyan Dialight Domino Printing Intercytex NextGen NXT Phytopharm Sagentia Group Sepura Xaar

Previous articles

Plastic Logic closes in on pilot production for 'disruptive' high-res plastic e-readers

Briefs: Stem Cell Sciences signs licence deal with Cambridge Enterprise; Cambridge Consultants design wrist band for health, fitness

TTP, LingVitae set up new firm to salvage some of Plasmon's good work

MMI shares marked down after it reports a Genvax anti-cancer vaccine update

Xaar rejects a possible £130m plus bid by Danaher as “opportunistic”

CSR reports strong 4Q2009, “market traction” with renewed portfolio

Briefs: Amadeus invests in EnQii; Administrators appointed at Plasmon

Delay in contract talks hits TTP Comm's '05/'06 revenue, puts back break even date

Potential MMI investors not best pleased with unsettled claim by former boss

CamSemi raises £13m in ‘C Round’ funding; first products shipping in volume

Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com

Corporate profiles

 • Avlar BioVentures

Daniel Roach Investment Director

Avlar BioVentures Ltd was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund I (£21m) and Avlar Fund II (£43m). Avlar has invested in eighteen companies across a range of sub-sectors of the bioscience industries. Ten are still private, two have been merged, three have been bought

[Avlar BioVentures's profile]

Top20 Index

Currently: 159.05